Synthesis of N-[2-(2-methylpropoxy)ethyl]-N-{2-[(4-methoxy) phenylmethylthio]phenyl}-1-pyrrolidineethanamine (E)-2-butenedioate (1:1) salt (CERM 12816): a potential anti-anginal drug
摘要:
GERM 12816, which was required for metabolic studies, was labelled with [C-14] in the methylene carbon of the benzyl group. This involved eight steps starting from barium [C-14] carbonate and 4-methoxyphenylmagnesium bromide, with a 20% overall yield. The specific activity was 208 MBq mmol(-1) (5.6 mCi mmol(-1)).
Synthesis of N-[2-(2-methylpropoxy)ethyl]-N-{2-[(4-methoxy) phenylmethylthio]phenyl}-1-pyrrolidineethanamine (E)-2-butenedioate (1:1) salt (CERM 12816): a potential anti-anginal drug
摘要:
GERM 12816, which was required for metabolic studies, was labelled with [C-14] in the methylene carbon of the benzyl group. This involved eight steps starting from barium [C-14] carbonate and 4-methoxyphenylmagnesium bromide, with a 20% overall yield. The specific activity was 208 MBq mmol(-1) (5.6 mCi mmol(-1)).
Synthesis of N-[2-(2-methylpropoxy)ethyl]-N-{2-[(4-methoxy) phenylmethylthio]phenyl}-1-pyrrolidineethanamine (E)-2-butenedioate (1:1) salt (CERM 12816): a potential anti-anginal drug
GERM 12816, which was required for metabolic studies, was labelled with [C-14] in the methylene carbon of the benzyl group. This involved eight steps starting from barium [C-14] carbonate and 4-methoxyphenylmagnesium bromide, with a 20% overall yield. The specific activity was 208 MBq mmol(-1) (5.6 mCi mmol(-1)).